LY6G6D and neoplasm: Using public transcriptomic data, we identified LY6G6D as a CRC specific antigen within 11616 tumor samples from the Cancer Genome Atlas (TCGA), and 17588 normal samples from TCGA (normal adjacent, n=2150) and the Genotype-Tissue Expression project (GTEx, n=15438) (Supplemental Fig. 1A).